Crossref journal-article
Elsevier BV
The American Journal of Pathology (78)
Bibliography

Mucke, L., Yu, G.-Q., McConlogue, L., Rockenstein, E. M., Abraham, C. R., & Masliah, E. (2000). Astroglial Expression of Human α1-Antichymotrypsin Enhances Alzheimer-like Pathology in Amyloid Protein Precursor Transgenic Mice. The American Journal of Pathology, 157(6), 2003–2010.

Authors 6
  1. Lennart Mucke (first)
  2. Gui-Qiu Yu (additional)
  3. Lisa McConlogue (additional)
  4. Edward M. Rockenstein (additional)
  5. Carmela R. Abraham (additional)
  6. Eliezer Masliah (additional)
References 60 Referenced 106
  1. 10.1016/0092-8674(88)90462-X / Cell / Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease by Abraham (1988)
  2. {'key': '10.1016/S0002-9440(10)64839-0_bib2', 'first-page': '247', 'article-title': 'Alpha1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha1-antichymotrypsin immunostaining in the Alzheimer brain', 'volume': '138', 'author': 'Shoji', 'year': '1991', 'journal-title': 'Am J Pathol'} / Am J Pathol / Alpha1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha1-antichymotrypsin immunostaining in the Alzheimer brain by Shoji (1991)
  3. 10.1002/glia.440130304 / Glia / Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes by Johnson (1995)
  4. 10.1073/pnas.96.6.3228 / Proc Natl Acad Sci USA / Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models by Hsia (1999)
  5. 10.1523/JNEUROSCI.20-11-04050.2000 / J Neurosci / High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation by Mucke (2000)
  6. 10.1038/399a023 / Nature / Translating cell biology into therapeutic advances in Alzheimer's disease by Selkoe (1999)
  7. 10.1046/j.1365-2990.1999.00164.x / Neuropathol Appl Neurobiol / The amyloid precursor protein of Alzheimer's disease and the Aβ peptide by Storey (1999)
  8. 10.1097/00005072-199908000-00001 / J Neuropathol Exp Neurol / Intracellular APP processing and Aβ production in Alzheimer disease by Wilson (1999)
  9. 10.1046/j.1471-4159.1998.71051920.x / J Neurochem / Generation and regulation of beta-amyloid peptide variants by neurons by Gouras (1998)
  10. 10.1002/ana.410370303 / Ann Neurol / Evidence that Aβ42 is the real culprit in Alzheimer's disease by Younkin (1995)
  11. 10.1097/00005072-199811000-00012 / J Neuropathol Exp Neurol / Quantification of modified amyloid β peptides in Alzheimer disease and Down-syndrome brains by Hosoda (1998)
  12. 10.1038/373523a0 / Nature / Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein by Games (1995)
  13. 10.1074/jbc.270.47.28257 / J Biol Chem / Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of transgenic mice and humans with Alzheimer's disease by Rockenstein (1995)
  14. 10.1523/JNEUROSCI.16-18-05795.1996 / J Neurosci / Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease by Masliah (1996)
  15. 10.1073/pnas.94.4.1550 / Proc Natl Acad Sci USA / Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease by Johnson-Wood (1997)
  16. 10.1146/annurev.neuro.21.1.479 / Annu Rev Neurosci / Mutant genes in familial Alzheimer's disease and transgenic models by Price (1998)
  17. 10.1002/(SICI)1097-4547(19961001)46:1<58::AID-JNR8>3.0.CO;2-E / J Neurosci Res / Relative efficacies of amyloid β peptide (Aβ) binding proteins in Aβ aggregation by Webster (1996)
  18. 10.1016/0197-4580(90)90045-2 / Neurobiol Aging / α1-antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α1-antichymotrypsin by Abraham (1990)
  19. 10.1016/S0021-9258(17)33954-6 / J Biol Chem / The serpin superfamily of proteinase inhibitors: structure, function, and regulation by Potempa (1994)
  20. {'key': '10.1016/S0002-9440(10)64839-0_bib20', 'first-page': '827', 'article-title': "Astrocytes in Alzheimer's disease gray matter express α1-antichymotrypsin mRNA", 'volume': '135', 'author': 'Pasternack', 'year': '1989', 'journal-title': 'Am J Pathol'} / Am J Pathol / Astrocytes in Alzheimer's disease gray matter express α1-antichymotrypsin mRNA by Pasternack (1989)
  21. 10.1016/0197-4580(91)90079-Y / Neurobiol Aging / Developmental expression of alpha1-antichymotrypsin in brain may be related to astrogliosis by Koo (1991)
  22. 10.1038/372092a0 / Nature / Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments by Ma (1994)
  23. 10.1038/nsb0896-668 / Nat Struct Biol / A specific structural interaction of Alzheimer's peptide 65 β1-42 with α1-antichymotrypsin by Janciauskiene (1996)
  24. 10.1111/j.1471-4159.1993.tb03568.x / J Neurochem / α1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence-specific and induces fibril disaggregation in vitro by Fraser (1993)
  25. 10.1073/pnas.92.6.2313 / Proc Natl Acad Sci USA / α1-antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation by Eriksson (1995)
  26. 10.1073/pnas.95.6.3275 / Proc Natl Acad Sci USA / α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation by Hughes (1998)
  27. 10.1016/0197-4580(96)00112-1 / Neurobiol Aging / Alzheimer Aβ neurotoxicity: promotion by antichymotrypsin, apoE4; inhibition by Aβ-related peptides by Ma (1996)
  28. 10.1016/0304-3940(96)13082-2 / Neurosci Lett / α1-antichymotrypsin interaction with Aβ(1-42) does not inhibit fibril formation but attenuates the peptide toxicity by Aksenov (1996)
  29. 10.1016/0304-3940(96)12717-8 / Neurosci Lett / α-1-Antichymotrypsin interaction with Aβ (1-40) inhibits fibril formation but does not affect the peptide toxicity by Aksenova (1996)
  30. 10.1111/j.1460-9568.1997.tb01425.x / Eur J Neurosci / Serpins inhibit the toxicity of amyloid peptides by Schubert (1997)
  31. 10.1038/367188a0 / Nature / Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice by Toggas (1994)
  32. 10.1016/S0002-9440(10)65489-2 / Am J Pathol / Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors by Huang (1999)
  33. {'key': '10.1016/S0002-9440(10)64839-0_bib33', 'first-page': '53', 'article-title': 'Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1', 'volume': '147', 'author': 'Wyss-Coray', 'year': '1995', 'journal-title': 'Am J Pathol'} / Am J Pathol / Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1 by Wyss-Coray (1995)
  34. 10.1038/39321 / Nature / Amyloidogenic role of cytokine TGF-β1 in transgenic mice and Alzheimer's disease by Wyss-Coray (1997)
  35. 10.1007/BF03401708 / Mol Med / Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases by Barelli (1997)
  36. 10.1016/0006-8993(94)90767-6 / Brain Res / Synaptotrophic effects of human amyloid β protein precursor in the cortex of transgenic mice by Mucke (1994)
  37. 10.1523/JNEUROSCI.19-12-04867.1999 / J Neurosci / Expression of human apolipoprotein E3 or E4 in the brains of Apoe−/− mice: isoform-specific effects on neurodegeneration by Buttini (1999)
  38. 10.1002/ana.410300410 / Ann Neurol / Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment by Terry (1991)
  39. 10.1016/0197-4580(92)90111-A / Neurobiol Aging / Regional synaptic pathology in Alzheimer's disease by Honer (1992)
  40. 10.1016/0304-3940(94)90121-X / Neurosci Lett / Synaptic and neuritic alterations during the progression of Alzheimer's disease by Masliah (1994)
  41. 10.1016/0197-4580(95)00013-5 / Neurobiol Aging / Correlations of synaptic and pathological markers with cognition of the elderly by Dickson (1995)
  42. 10.1097/00005072-199708000-00011 / J Neuropathol Exp Neurol / Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease by Sze (1997)
  43. 10.1016/0014-4886(91)90169-D / Exp Neurol / Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP43 in the dentate gyrus of the adult rat by Masliah (1991)
  44. 10.1007/BF00294446 / Acta Neuropathol / Distribution pattern and functional state of α1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease by Rozemuller (1991)
  45. 10.1074/jbc.273.43.28360 / J Biol Chem / Alzheimer's peptide Aβ1-42 binds to two β-sheets of α1-antichymotrypsin and transforms it from inhibitor to substrate by Janciauskiene (1998)
  46. 10.1016/0896-6273(94)90165-1 / Neuron / An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar a β-amyloid in rat brain by Snow (1994)
  47. 10.1016/0304-3940(92)90444-C / Neurosci Lett / Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid by Wisniewski (1992)
  48. 10.1074/jbc.274.26.18777 / J Biol Chem / Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-β peptide degradation by Yamin (1999)
  49. 10.1038/ng1197-263 / Nat Genet / Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition by Bales (1997)
  50. {'key': '10.1016/S0002-9440(10)64839-0_bib50', 'first-page': '22', 'article-title': "TGF-β1 modulates brain amyloid deposition and induces Alzheimer's disease like microvascular abnormalities in transgenic mice", 'volume': '25', 'author': 'Wyss-Coray', 'year': '1999', 'journal-title': 'Soc Neurosci Abstr'} / Soc Neurosci Abstr / TGF-β1 modulates brain amyloid deposition and induces Alzheimer's disease like microvascular abnormalities in transgenic mice by Wyss-Coray (1999)
  51. 10.1016/S0197-4580(96)00170-4 / Neurobiol Aging / β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease by Cummings (1996)
  52. 10.1097/00005072-199655100-00001 / J Neuropathol Exp Neurol / The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis by Terry (1996)
  53. 10.1097/00005072-199705000-00009 / J Neuropathol Exp Neurol / The mean Aβ load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease by Bartoo (1997)
  54. {'key': '10.1016/S0002-9440(10)64839-0_bib54', 'first-page': '558', 'article-title': 'The ‘amyloid cascade hypothesis’ of AD: decoy or real McCoy?', 'volume': '20', 'author': 'Davis', 'year': '1997', 'journal-title': 'Trends Neurosci'} / Trends Neurosci / The ‘amyloid cascade hypothesis’ of AD: decoy or real McCoy? by Davis (1997)
  55. 10.1002/ana.410410106 / Ann Neurol / Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease by Gomez-Isla (1997)
  56. 10.1016/S0002-9440(10)65184-X / Am J Pathol / Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease by Lue (1999)
  57. 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M / Ann Neurol / Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease by McLean (1999)
  58. 10.1097/00005072-199812000-00003 / J Neuropathol Exp Neurol / Aβ associated neuropil changes: correlation with neuronal loss and dementia by Knowles (1998)
  59. 10.1073/pnas.96.9.5274 / Proc Natl Acad Sci USA / Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease by Knowles (1999)
  60. 10.1016/S0197-4580(00)00124-X / Neurobiol Aging / Inflammation and Alzheimer's disease. Neuroinflammation working group by Akiyama (2000)
Dates
Type When
Created 14 years, 7 months ago (Jan. 28, 2011, 12:02 a.m.)
Deposited 4 years, 5 months ago (March 31, 2021, 6:41 p.m.)
Indexed 1 month ago (Aug. 2, 2025, 1:25 a.m.)
Issued 24 years, 9 months ago (Dec. 1, 2000)
Published 24 years, 9 months ago (Dec. 1, 2000)
Published Print 24 years, 9 months ago (Dec. 1, 2000)
Funders 1
  1. National Institutes of Health 10.13039/100000002

    Region: Americas

    gov (National government)

    Labels3
    1. Institutos Nacionales de la Salud
    2. US National Institutes of Health
    3. NIH
    Awards4
    1. AG09905
    2. AG11385
    3. AG5131
    4. AG10869

@article{Mucke_2000, title={Astroglial Expression of Human α1-Antichymotrypsin Enhances Alzheimer-like Pathology in Amyloid Protein Precursor Transgenic Mice}, volume={157}, ISSN={0002-9440}, url={http://dx.doi.org/10.1016/s0002-9440(10)64839-0}, DOI={10.1016/s0002-9440(10)64839-0}, number={6}, journal={The American Journal of Pathology}, publisher={Elsevier BV}, author={Mucke, Lennart and Yu, Gui-Qiu and McConlogue, Lisa and Rockenstein, Edward M. and Abraham, Carmela R. and Masliah, Eliezer}, year={2000}, month=dec, pages={2003–2010} }